Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis

OBJECTIVES: To evaluate the risk of opportunistic infections (OIs) in patients with rheumatoid arthritis (RA) treated with tofacitinib. METHODS: Phase II, III and long-term extension clinical trial data (April 2013 data-cut) from the tofacitinib RA programme were reviewed. OIs defined a priori inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Winthrop, K L, Park, S-H, Gul, A, Cardiel, M H, Gomez-Reino, J J, Tanaka, Y, Kwok, K, Lukic, T, Mortensen, E, Ponce de Leon, D, Riese, R, Valdez, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893093/
https://www.ncbi.nlm.nih.gov/pubmed/26318385
http://dx.doi.org/10.1136/annrheumdis-2015-207319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893093/
https://www.ncbi.nlm.nih.gov/pubmed/26318385
http://dx.doi.org/10.1136/annrheumdis-2015-207319

Ejemplares similares